Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chemclin Diagnostics CoSHSE:688468 -2.97%67 Gross Margin % is 61.48% as of Mar. 2026, which is 17% below its 10-year median of 74.37. GuruFocus rates SHSE:688468 with a GF Score™ of 67/100 and a GF Value™ of ¥5.75 (Fairly Valued). The stock has 6 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Chemclin Diagnostics Co ranks better than 70.1% on this metric.
SHSE:688468's Gross Margin % is ranked better than 70.1% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.14
vs SHSE:688468: 65.25
Chemclin Diagnostics Co had a gross margin of 61.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Chemclin Diagnostics Co was -1.20% per year.
Chemclin Diagnostics Co (SHSE:688468) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Chemclin Diagnostics Co had a gross margin of 61.48% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Chemclin Diagnostics Co Gross Margin % Related Terms
Chemclin Diagnostics Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688468 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Chemclin Diagnostics Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemclin Diagnostics Co Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chemclin Diagnostics Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Chemclin Diagnostics Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Chemclin Diagnostics Co (SHSE:688468) has a Gross Margin % of 61.48% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Chemclin Diagnostics Co and its competitors. This is 17% below median its historical median of 74.37. Over the past decade, Chemclin Diagnostics Co's Gross Margin % has ranged from 65.25 to 75.36. According to the industry distribution chart, Chemclin Diagnostics Co ranks #58 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 29.9%.
Is Chemclin Diagnostics Co's Gross Margin % too high?
Chemclin Diagnostics Co's current Gross Margin % of 61.48% is 17% below median its 10-year median of 74.37. Over the past 10 years, this metric has ranged from a low of 65.25 to a high of 75.36. The Medical Diagnostics & Research industry median Gross Margin % is 51.14. Chemclin Diagnostics Co's value of 61.48% is 20.2% above this industry median. Based on the distribution chart, Chemclin Diagnostics Co ranks #58 out of 194 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Chemclin Diagnostics Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chemclin Diagnostics Co's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chemclin Diagnostics Co ranks #58 out of 194 companies for Gross Margin %. This puts Chemclin Diagnostics Co in the upper half of its industry. The industry median Gross Margin % is 51.14. Chemclin Diagnostics Co's value of 61.48% is 20.2% above this benchmark. Historically, Chemclin Diagnostics Co's own Gross Margin % has ranged from 65.25 to 75.36 over the past decade. While the company's 10-year median is 74.37 vs. the industry median of 51.14, Chemclin Diagnostics Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.14, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemclin Diagnostics Co's current Gross Margin % of 61.48% is 20.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Chemclin Diagnostics Co and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemclin Diagnostics Co's current Gross Margin % is 61.48%, which is 17% below median its own 10-year median of 74.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemclin Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Chemclin Diagnostics Co (SHSE:688468) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.75, compared to a current price of ¥5.55 — trading 3.5% below its estimated fair value. The current Gross Margin % is 61.48%, which is 17% below median its 10-year median of 74.37 and 20.2% above the Medical Diagnostics & Research industry median of 51.14. Chemclin Diagnostics Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Chemclin Diagnostics Co (SHSE:688468), the current Gross Margin % is 61.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemclin Diagnostics Co (SHSE:688468) Overvalued in 2026?
Based on GuruFocus' analysis, Chemclin Diagnostics Co stock appears to be undervalued.
The current stock price of ¥5.55 is trading 3.5% below its estimated GF Value™ of ¥5.75.
GuruFocus considers Chemclin Diagnostics Co to be Fairly Valued.
Key valuation signals for SHSE:688468:
Gross Margin %: 61.48% (17% below median its 10-year median of 74.37)
GF Value™: ¥5.75 vs. price of ¥5.55 (3.5% below fair value)
Industry Position: 20.2% above the Medical Diagnostics & Research median (#58 of 194)
No single metric tells the full story. See the SHSE:688468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemclin Diagnostics Co Ltd is engaged in the development, production and sales of clinical immunochemiluminescence diagnostic testing reagents and instruments.
67GF Score
Get the complete analysis for SHSE:688468
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688468 has been successfully added to your 
